ClinicalTrials.Veeva

Menu

The Rate of Successful Intubation and the Required Time for Intubation, Using Vie Scope and Macintosh Laryngoscope Will be Compared, in Order to Evaluate the Efficacy of Vie Scope in Comparison With Macintosh in Expected Easy Airways.

S

St. Andrew's General Hospital, Patras, Greece

Status

Completed

Conditions

Laryngoscopy

Treatments

Device: Vie Scope
Device: Macintosh laryngoscope

Study type

Interventional

Funder types

Other

Identifiers

NCT06149338
141/09.07.2023

Details and patient eligibility

About

The rate of successful intubation and the required time for intubation, using Vie Scope and Macintosh Laryngoscope will be compared, in order to evaluate the efficacy of Vie Scope in comparison with Macintosh in expected easy airways. Hence, a prospective randomized controlled single-blind superiority clinical trial will be conducted.

Inclusion criteria: patients of both sexes, positive or negative rapid test for COVID-19 or possible contamination, age ≥18 years old, BMI: 18.5 - 30 kg/m2, visualization of the glottis grade 1 or 2, according to Cormack-Lehane Classification.

Exclusion criteria: age under 18 years old, BMI under 18.5 kg/m2 and BMI over 30 kg/m2, visualization of the glottis grade 3 - 4, according to Cormack-Lehane Classification.

The laryngoscopy and intubation of the patients will be attempted by the same person-resident of Anesthesiology, under the supervision of experienced Anesthesiologist consultants.

Enrollment

264 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients of both sexes
  • Positive or negative rapid test for COVID-19 or possible contamination
  • Age ≥18 years old
  • BMI: 18.5 - 30 kg/m2
  • Visualization of the glottis grade 1 or 2, according to Cormack-Lehane Classification.

Exclusion criteria

  • Age under 18 years old
  • BMI under 18.5 kg/m2 and BMI over 30 kg/m2
  • Visualization of the glottis grade 3 - 4, according to Cormack-Lehane Classification.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

264 participants in 2 patient groups

Patients being intubated using Macintosh laryngoscope
Experimental group
Treatment:
Device: Macintosh laryngoscope
Patients being intubated using Vie Scope laryngoscope
Experimental group
Treatment:
Device: Vie Scope

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Vasileios Boviatsis, Medical Doctor; Ilias Theodoropoulos

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems